Insecticides India Ltd Q1 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/f443vfsx4eed6oss66td0dxo.pdf

Key Takeaways


Premiumization & Margin Transformation

Rajesh Aggarwal: "We were a Company which was working on the lowest margins in the industry. I want to change that outlook and I want to work with premium products."

Product Pipeline & R&D Engine

Rajesh Aggarwal: "Our major concentration is to build these superstars for tomorrow."

Demand Environment & Season Dynamics

Rajesh Aggarwal: "The rainfalls in June and July were not constant. So, what has happened is that the season has extended... the difference is 1 month, 2 months, 1.5 months from area to area, village to village, farmer to farmer which means the season is prolonged."

Generics Pressure & Strategic Shift

Rajesh Aggarwal: "I don't want to jump into the fight of quantity. Rather, I want a quality business."

Capacity Expansion & Backward Integration


Guidance & Commitments

CommitmentSpecificsTimeline
Shinwa salesMore than double salesThis fiscal year
Maharatna segment revenueTouch Rs. 1,000 croresThis fiscal itself
Volume growth15% to 20%FY25
Value growthRoughly near to 10%FY25
Premium segment growthFocus Maharatna/Maharatna to grow 15% to 20%FY25
Full-year EBITDA marginRemain double-digit, close to 11% possible; could surpass 11% if monsoons holdFY25
Annual EBITDA margin improvementAt least 100 bps per annumOngoing
Dahej plant state approvalExpected within a monthAugust/early September 2024
Dahej plant contribution startProduction begins, contribution from DecemberDecember 2024
Dahej plant full revenue potentialRs. 250-300 croresNext fiscal year (FY26)
New product launches6-7 products every year, most in 9(3) categoryOngoing annual target
Sotanala project completionCAPEX of Rs. 100 croresNext 1-1.5 years
Premium product mix targetTake Focus Maharatna and Maharatna to 75% of portfolioNext 3 to 4 years
Inventory targetBring levels down to 650 plus-minus at end of all quartersOngoing

Key Metrics

MetricQ1 FY25
Revenue from operations₹657 cr, vs ₹640 cr in Q1 FY24
EBITDA₹72 cr, vs ₹46 cr in Q1 FY24
PAT₹49 cr, vs ₹29 cr in Q1 FY24
EBITDA margin~11.0% (₹72 cr on ₹657 cr, per analyst's math), improvement of more than 300 bps YoY
Volume growth15% YoY
Value growth3% YoY
Revenue growth guidance (FY25)Near double digit
Volume growth guidance (FY25)15% to 20%
Premium products share of B2C sales~60%, vs 59% in FY24 and 51% in FY23
Focus Maharatna and Maharatna gross margin40%+ in Q1, vs ~35% normally
Generic products gross margin~12% to 15%
Segment mix: Herbicides~61% of revenue
Segment mix: Insecticides~33% of revenue
Segment mix: Fungicides~4% of revenue
Channel mix: B2C~71% of revenue
Channel mix: B2B~26% of revenue
Channel mix: Exports~3% of revenue
Inventory~₹700 cr at end of Q1, expected to normalize to ₹650 cr plus/minus
Employee count1,700, up by 100+ in Q1
Farmer meetings conductedMore than 6,500 in Q1
Farmers reachedMore than 4 lakh in Q1
Distributor countOver 7,500, up from 6,600
CAPEX plan (Sotanala project)₹100 cr
Dahej L&T plant investmentOver ₹105 cr spent, total reactors doubled to 200
Dahej plant revenue potential₹250 to ₹300 cr in first full year of operation
New product contribution (last 4 years)33% of B2C sales (~₹500 cr of ~₹1,500 cr)
Shinwa net sales (FY24)₹100 cr, expected to more than double in FY25
Maharatna segment contribution (FY24)~₹800 cr+, expected to touch ₹1,000 cr in FY25